Study of effect of Gomutradi Kshara in Medoroga (dyslipidaemia)

Phase 2

Completed

• Conditions: Health Condition 1: E785- Hyperlipidemia, unspecified

• Registration Number: CTRI/2019/04/018826
• Lead Sponsor: ational Institute of Ayurveda

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-02-27
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

1. Patients between the age group of 18-60 years of either sex.

2. Diagnosed & confirmed cases of Dyslipidaemia ( Medoroga) on the basis of criteria given by NCEP-ATPIII. (If any one of the following)

a) Serum Cholesterol >= 200 mg/dl

b) Serum Triglycerides >= 150 mg/dl

c) LDL Cholesterol >= 130 mg/dl

d) HDL Cholesterol < 40 mg/dl

3. Willing and able to participate in the study for 1 months.

Exclusion Criteria

1. Patients having medical history of-

a) Unstable angina

b) Patients who have a past history of Atrial

Fibrillation, Acute Coronary Syndrome,

Myocardial Infarction, Stroke or severe

Arrhythmia in the last six months.

c) Patients on prolonged ( > 6 weeks)

medication with corticosteroids,

antidepressants, anticholinergics,

immunosuppressants, oestrogen replacement

therapy etc. or any other drugs that may have

an influence on the outcome of the study.

d) Symptomatic patient with clinical evidence

of Heart failure.

e) Patients with poorly controlled hypertension

(systolic >160 and diastolic >100 mm of Hg)

f) Uncontrolled Diabetes Mellitus.

g) Impaired Renal function (Creatinine >2mg/dl).

h) ALT and AST > 2 times of upper limit of

normal (40 mg/dl).

i) Hypothyroidism.

j) Patients with evidence of malignancy.

k) Patients on oral contraceptives.

l) Alcoholics and /or drug abusers.

m) Hypersensitivity to any of the trial drugs

or their ingredients.

n) Patients who have completed participation in

any other clinical trial drugs or their

ingredients.

o) Patients who have received any cholesterol

lowering medication (Modern Drug within last

two weeks.

2. Pregnancy, Lactation and patients having

Dyslipidaemia due to drugs e.g.

Glucocorticoids ,Diuretics etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified